A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)

Summary

The purpose of this study is to assess the long-term safety and tolerability of aticaprant administered as adjunctive therapy to a current antidepressant (selective serotonin reuptake inhibitor \[SSRI\] or serotonin and norepinephrine reuptake inhibitor \[SNRI\]) in all participants with major depressive disorder (MDD).

Timeline

Start

2022-09-22

Primary completion

2025-04-25

Completion

2025-05-08

Outcome

Outcome not reported

Stopped: “The study was Early Terminated as per Sponsor's decision (communicated to sites on 06Mar2025)”

Drugs

Indications